The Myasthenia Gravis Disease Market Size is projected to reach USD 1.97 billion by 2032 at 7.9% CAGR during the forecast period 2023-2032.
Myasthenia Gravis (MG) is a rare autoimmune disorder characterized by muscle weakness and fatigue, impacting the neuromuscular junction. This chronic condition occurs when the immune system mistakenly attacks the receptors responsible for...
English
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian